A more complete biopsy.

Actionable tumor mutation testing and immune profiling through a simple blood draw.

Biodesix Lung Reflex® testing complements tissue testing and broad tumor profiling with results in less than 72 hours from receipt of a blood sample.

Incorporate Biodesix Lung Reflex® testing into your practice today


When using Biodesix Mobile Phlebotomy services, Test Request Forms can be submitted digitally. The Customer Care team takes it from there.

If you are interested in submitting online orders through the Biodesix Physician Portal, contact Customer Care at 866.432.5930 or custcare@biodesix.com.


The Biodesix Lung Reflex kit contains a Test Request Form and instructions for collecting the blood specimens with the provided collection devices. Package the signed and dated form with the specimen in the kit box and ship in the prepaid FedEx envelope included with each kit.

Biodesix Lung Reflex Educational Video Series

Support multi-disciplinary treatment decisions with actionable mutation status and immune profiling at the time of the first case review

Actionable Tumor Mutation Status

The GeneStrat® test identifies the most common tumor mutations with guideline-recommended targeted therapies: EGFR, EML4-ALK, KRAS, BRAF, ROS-1, and RET.

These tumor mutations are also the focus of several studies evaluating their potential for adjuvant therapy in resectable early stage NSCLC.

Prognostic across Treatment Types

Clinical studies on the VeriStrat® test have repeatedly shown that the test identifies patients with a chronic inflammatory state who have shorter overall survival and should be evaluated for alternative treatment plans and monitored closely for disease progression.

Recent data has also shown the test identifies patients with aggressive early stage disease that may benefit from enhanced disease surveillance or adjuvant treatments.

Review Publications and Posters

Fast Turnaround Time

Test results are delivered in less than 72 hours to provide molecular and prognostic information at the time of the first multi-disciplinary meeting or oncology appointment.

Preserve Tissue

Blood-based molecular testing preserves tissue for other tests that support NSCLC treatment strategies.

Disease Monitoring

Biodesix Lung Reflex testing can be used serially to monitor changes in tumor mutation status or the patient’s immune response to their lung cancer.

Billing & Reimbursement

Biodesix Lung Reflex is covered by Medicare and many private payers for all patients with NSCLC. This broad coverage allows the testing strategy to be used as a complement to other tests that may only be indicated for patients with advanced stage lung cancer or tests that only covered once per patient.

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our GDPR Notice.